CD8A and melanoma: In contrast, in melanoma tumors with low levels of β-catenin, DCs and CD8+ T cells migrated into the tumor and the tumor-killing activities of CD8+ T cells could be unleashed or enhanced by the use of checkpoint inhibitors11.